Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Applied Science Laboratories Releases Revolutionary Eye Tracking Analysis Software

March 15, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., March 15, 2011 /- Applied Science Laboratories, the true authority on eye tracking, has released its highly anticipated analysis software, ASL Results for the Mobile Eye solution. This revolutionary program makes measuring consumer response, human behavior and physiology...

Southern Home Medical Equipment Engages Northern Virginia Based Waterford Holdings Group to Evaluate and Consider Acquisition Candidates in the Mid-Atlantic Area

March 15, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

LYMAN, S.C., March 15, 2011 /- Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, has targeted the Mid-Atlantic region for expansion and growth.  After two...

NewCardio to Conduct Corporate Update Conference Call on March 29, 2011

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., March 15, 2011 /- NewCardio, Inc. (OTC Bulletin Board: NWCI ), a cardiovascular diagnostic solutions developer, announced today that the Company expects to file its Form 10-K for the year ended December 31, 2010 on March 29, 2011 and management will conduct a...

Advertisement

Matakina and PenRad Sign Letter of Intent to Display Volparaâ„¢ Volumetric Breast Density Results on Mammography Review Station

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

LAS VEGAS, March 15, 2011 /- Matakina International, Limited of New Zealand and PenRad Technologies, Inc., a leader in medical image and information management, today announced that the companies have signed a Letter of Intent (LOI) to use the PenRad Mammography Information System (MIS)...

Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

WESTFORD, Mass., March 15, 2011 /- Cynosure, Inc. (Nasdaq: CYNO ), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that two of its newest workstations for laser-assisted lipolysis and non-invasive cellulite...

Vystar® Corporation Secures a $3M Credit Facility to Fund Growth

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, March 15, 2011 /- Vystar® Corporation (OTC Bulletin Board: VYST ), the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins found in natural rubber latex, has secured $3 million in debt...

NAFE Names Lilly to Top 50 Companies for Executive Women

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, March 15, 2011 /- Eli Lilly and Company (NYSE: LLY ) has been named to the 2011 NAFE Top 50 Companies for Executive Women by the National Association for Female Executives (NAFE).  The list recognizes organizations whose policies and practices encourage women's...

iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that it has commenced patient recruitment in an open-label, proof-of-concept Phase 1b study of its lead compound ITX-5061 in...

Advertisement

iTherX Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that Stefan Zeuzem, M.D., has joined the company as Chair of the Scientific and Clinical Advisory Board.  Dr. Zeuzem will...

LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

CENTENNIAL, Colo. and ALISO VIEJO, Calif., March 15, 2011 /- LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry...

Nottingham University Hospital is First U.K. User of Elekta's Electronic Medical Record Workspace for Image Guided Radiation Therapy

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

NOTTINGHAM, England, March 15, 2011 /- Delivering Image Guided Radiation Therapy (IGRT) effectively and safely involves careful coordination of sophisticated systems, such as the therapy machine and its imaging subsystems, as well as the electronic medical record (EMR) used to schedule...

Oconee Medical Center is Winner of Siemens 'Who Inspires You?' Video Contest

March 15, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

LAS VEGAS, March 15, 2011 /- Oconee Medical Center in Seneca, S.C., is the winner of Siemens "Who Inspires You?" video contest and the recipient of a new MAMMOMAT® Inspiration, Siemens next generation full-field digital mammography system. (Photo:...

OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical Inc. (OTC Bulletin Board: ONCSD ), a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. (NYSE Amex:...

Advertisement

Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., March 15, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. (OTC Bulletin Board:...

OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical, Inc. (OTC Bulletin Board: ONCSD ) announced today that Mr. Punit Dhillon, President and CEO, will present a company overview on Wednesday, March 16 at 2:00 pm PT at the ROTH 23rd Annual Growth Stock Conference being held at the Ritz-Carlton,...

ARMSRx and 84 Lumber Hammer Down Rx Costs...Again

March 15, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

EIGHTY FOUR, Pa., March 15, 2011 /- ARMSRx Pharmacy Benefit Consulting, the nation's leading Pharmacy Benefit consulting firm, has consistently provided successful recommendations for their clients. On February 16th, ARMSRx presented results to one of their premier clients, 84 Lumber....

Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017...

Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017...

Reportlinker Adds Insulin Lispro - Comprehensive Patent Search

March 14, 2011 11:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Insulin Lispro - Comprehensive patent search http://www.reportlinker.com/p0447411/Insulin-Lispro----Comprehensive-patent-search.html Eliminate unnecessary risk with the...

Streamline Health Appoints Rick Leach as Senior Vice President and Chief Marketing Officer

March 14, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, March 14, 2011 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ), a market leading provider of document workflow solutions for hospitals, announced today that Rick Leach has been appointed Senior Vice President and Chief Marketing Officer effective March 14, 2011. With more...

FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium

March 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., March. 14, 2011 /- Life Technologies Corporation (Nasdaq: LIFE ) today announced it has received FDA 510(k) clearance for StemPro® MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a...

LaVoie Group Wins Two Mercury Excellence Awards

March 14, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

SALEM, Mass., March 14, 2011 /- LaVoie Group, the acknowledged leader in life science and pharmaceutical communications, announced today that it has received a Gold Award in the 24th Annual International Mercury Excellence Awards 2010/2011 competition, given annually by MerComm, Inc....

Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology

March 14, 2011 12:32 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., March 14, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its partner, ChronTech Pharma AB (formerly Tripep AB), has initiated a Phase...

Medical Imaging Taps New Levels of Graphics Display Technologies

March 11, 2011 9:34 am | by Nancy Pantone and Christine A. Van De Graaf | Articles | Comments

A major growth area in medical device technology, medical imaging is gaining momentum in the number of clinical applications for which it’s being prescribed. Now, new COM Express technology enables multi-display functionality for healthcare applications. This article reviews the new technology.

Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint

March 11, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. and LONDON, March 11, 2011 /- Tolerx, Inc. and GlaxoSmithKline (GSK) today announced that the Phase 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint of change in C-peptide at month 12...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading